SKB518 for injection

DRUG2 trials

Sponsors

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

Conditions

Advanced Gynecological MalignanciesAdvanced Solid Tumors

Phase 1

A Study of SKB518 in Patients With Advanced Solid Tumors

RecruitingNCT06428331

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Advanced Solid Tumors

Start: 2024-07-04End: 2026-06-30Target: 150Updated: 2025-12-05

Phase 2

A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors

Not yet recruitingNCT07448922

Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.Advanced Gynecological Malignancies

Start: 2026-03-25End: 2028-09-30Target: 290Updated: 2026-03-04